check_circleStudy Completed
Epidemiologic factors
Bayer Identifier:
14317
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Patient characteristics in daily radiological practice of Gadovist® application (PATRON)
Trial purpose
To evaluate patient characteristics in the current daily radiological practice of Gadovist application. Special focus will be laid on the individual risk factors of patients, the indications for and the dose of Gadovist application.
Secondary objective is to prove the known safety profile (especially rare adverse events) of Gadovist and to collect data on handling problems with different application forms (one questionnaire per center).
Secondary objective is to prove the known safety profile (especially rare adverse events) of Gadovist and to collect data on handling problems with different application forms (one questionnaire per center).
Key Participants Requirements
Sex
BothAge
7 - N/ATrial summary
Enrollment Goal
3711Trial Dates
March 2009 - November 2011Phase
N/ACould I Receive a placebo
NoProducts
Gadavist/Gadovist (Gadobutrol, BAY86-4875)Accepts Healthy Volunteer
NoWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Many Locations, Germany |
Primary Outcome
- Patient Profiledate_rangeTime Frame:At day of applicationenhanced_encryptionNoSafety Issue:
Secondary Outcome
- Dosing of Gadovist in different indicationsdate_rangeTime Frame:At time of applicationenhanced_encryptionNoSafety Issue:
- Adverse Eventsdate_rangeTime Frame:Throughout and after applicationenhanced_encryptionYesSafety Issue:
Trial design
Trial Type
ObservationalIntervention Type
Biological/VaccineTrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A